Seeing Machines' visual analyser:
This article was originally published in Clinica
Imaging software firm Seeing Machines, of Canberra, Australia, has received 510(k) marketing clearance from the US FDA for its revolutionary new medical device, the TrueField Analyzer (TFA). The TFA aids the measurement of defects in a patient's visual field, a crucial step in the detection and management of diseases of the vision system, including glaucoma, age related macular degeneration and diabetic retinopathy. The device measures both eyes simultaneously, and the entire test of both eyes can be completed in around five minutes, including rest breaks within the test. US launch of the tool is expected later this year - Seeing Machines intends to exhibit the device at the upcoming annual meeting of the American Academy of Ophthalmology in New Orleans in November. The company received a grant of Aus$113,000 (US$90,376) from the Australian government in June 2006 to fund development of the device (see Clinica No 1209, p 12).